Welcome to DNAtrix

DNAtrix is a Texas-based biotechnology company founded by world class physicians and scientists from the UCSF Helen Diller Comprehensive Cancer Center and MD Anderson Cancer Center.

The company is developing a new generation of oncolytic virus technology designed to destroy cancer cells while leaving healthy cells unharmed. The novel DNAtrix technology, Delta-24-RGD, has several advantages for treating cancer. Animal data suggest that Delta-24-RGD can enhance both radiation- and chemo-therapy. The company’s goal is to fast-track this potential breakthrough therapy through the drug development process in the United States.

Towards this goal, the patented technology in currently being tested in human clinical trials at MD Anderson Cancer center for the treatment of Glioblastoma Multiforme, an incurable brain cancer. MORE